Depreciation, Depletion and Amortization of AEON Biopharma, Inc. from 31 Dec 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
AEON Biopharma, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
  • AEON Biopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $19,000, a 24% decline year-over-year.
  • AEON Biopharma, Inc. annual Depreciation, Depletion and Amortization for 2024 was $97,000.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)

AEON Biopharma, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $19,000 -$6,000 -24% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $25,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q3 2023 $21,000 22 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q1 2023 $25,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1

AEON Biopharma, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $97,000 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2022 $68,000 01 Jan 2022 31 Dec 2022 10-K/A 14 May 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.